1. Home
  2. FIVN vs AMLX Comparison

FIVN vs AMLX Comparison

Compare FIVN & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five9 Inc.

FIVN

Five9 Inc.

HOLD

Current Price

$27.45

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$20.35

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVN
AMLX
Founded
2001
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
FIVN
AMLX
Price
$27.45
$20.35
Analyst Decision
Buy
Strong Buy
Analyst Count
18
9
Target Price
$26.06
$21.56
AVG Volume (30 Days)
2.4M
1.6M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
364.71
65.46
EPS
0.21
N/A
Revenue
$1,149,088,000.00
$380,786,000.00
Revenue This Year
$11.39
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
$132.40
N/A
Revenue Growth
10.28
1612.94
52 Week Low
$13.29
$7.48
52 Week High
$28.86
$20.90

Technical Indicators

Market Signals
Indicator
FIVN
AMLX
Relative Strength Index (RSI) 63.52 59.66
Support Level $17.66 $12.14
Resistance Level N/A N/A
Average True Range (ATR) 1.67 1.28
MACD 0.23 0.13
Stochastic Oscillator 81.91 68.10

Price Performance

Historical Comparison
FIVN
AMLX

About FIVN Five9 Inc.

Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

Share on Social Networks: